Stay updated on BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL

Sign up to get notified when there's something new on the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page.
Latest website image capture
Clouds background image

Latest updates to the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page

  1. Check
    2 days ago
    Change Detected
    Summary
    A notice about NIH’s terminology transition was added above the 403 error page. The site revision changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:22:07.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer now displays revision v3.7.1 instead of v3.7.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:33:07.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    Core elements such as investigator sites and locations and several essential study documents have been removed. The update also eliminates IPD sharing information, affecting access to important materials and data-sharing plans related to the trial.
    Difference
    19%
    Check dated 2026-09-23T00:31:31.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.7.0, replacing the previous v3.6.6 tag, indicating a site version update rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-09-15T23:28:55.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6, indicating a small software release; no changes to study details are described.
    Difference
    0.0%
    Check dated 2026-09-01T19:44:06.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Two new NIH grant/contract entries (2016 and 2023) were added to the study's funding identifiers, updating the record of government support for the trial. This reflects expanded attribution of funding in the study's metadata.
    Difference
    0.1%
    Check dated 2026-08-25T19:47:33.000Z thumbnail image

Stay in the know with updates to BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL

Enter your email address, and we'll notify you when there's something new on the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page.